section name header

Indications

High Alert

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CNS: confusion, paradoxical excitation/delirium, postoperative depression, postoperative drowsiness.

EENT: blurred/double vision.

Resp: APNEA, LARYNGOSPASM, allergic bronchospasm, respiratory depression.

CV: arrhythmias, bradycardia, circulatory depression, hypotension.

GI: biliary spasm, nausea/vomiting ( in children).

Derm: facial itching.

MS: skeletal and thoracic muscle rigidity, shivering ( in children).

Interactions

Drug-Drug:

Availability

(Generic available)

Route/Dosage

see Calculator

Induction of Anesthesia

Maintenance of Anesthesia

Continuation as an Analgesic in Immediately Postoperative Period

Monitored Anesthesia Care (Remifentanil Alone)

Monitored Anesthesia Care (Remifentanil + Midazolam)

Coronary Artery Bypass Surgery

US Brand Names

Ultiva

Action

Therapeutic Effects:

Classifications

Therapeutic Classification: opioid analgesics

Pharmacologic Classification: opioid agonists

Pharmacokinetics

Absorption: IV administration results in complete bioavailability.

Distribution: Widely distributed.

Metabolism/Excretion: Metabolized by blood and tissue esterases, metabolites are excreted by the kidneys.

Half-life: 3–10 min.

Contr. Subst. Schedule

Schedule II (C-II)

Time/Action Profile

(analgesia†)

ROUTEONSETPEAKDURATION
IVrapid3–5 min5–10 min

†Respiratory depression may last longer than analgesia.

Patient/Family Teaching

Pronunciation

re-mi-FEN-ta-nil audio

Code

NDC Code*